                         SEQUENCE LISTING

<110>  DuPont Nutrition Biosciences ApS
 
<120>  Method

<130>  P105213PCT

<150>  EP13186175.9
<151>  2013-09-26

<150>  EP13186177.5
<151>  2013-09-26

<150>  EP13175650.4
<151>  2013-07-09

<150>  EP13175649.6
<151>  2013-07-09

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide FarciTaqPr

<400>  1
tctgcattat agtttgtttc cacgtgtgg                                         29


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide A08rhaPr

<400>  2
cggtccaatg ggcagcctct                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer FarciTaq-L Forward

<400>  3
atcgaagagc caaaaccaaa                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer FarciTaq-R reverse

<400>  4
tcattttggc aaggatcaag                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer A08rha-L forward

<400>  5
ttcaaccacc agtgtgtcct                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer A08rha-L reverse

<400>  6
tcttccgtcc ggaactaatc                                                   20


